DoW Neurofibromatosis Research Academy - Scholar Award
This grant supports early-career researchers within 10 years of their terminal degree to conduct innovative neurofibromatosis research as part of the Neurofibromatosis Research Academy, with required mentorship.
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: September 8, 2026 (Pre-Application/LOI) | September 22, 2026 (Full Application)
Funding Amounts: ~$3.6M total; up to $1.2M total costs per award over 4 years; ~3 awards expected
Summary: Supports early-career independent investigators to conduct innovative neurofibromatosis research with career development in a collaborative academy environment.
Key Information: Clinical trials are not allowed; Scholar must be ≤10 years from terminal degree at application deadline.
Description
This funding opportunity is part of the FY26 Neurofibromatosis Research Program (NFRP) and is designed to support early-career independent investigators (Scholars) as they join the Neurofibromatosis Research Academy. The award funds research projects—basic, translational, or clinical (not clinical trials)—that address at least one of the NFRP’s FY26 Areas of Emphasis and provides intensive mentorship and career development in a collaborative, multi-institutional environment. The overarching goals are to advance impactful research in neurofibromatosis (NF1, NF2, and schwannomatosis) and foster the next generation of leaders in the field.
